213 related articles for article (PubMed ID: 30004815)
1. Sex Differences in Efficacy and Toxicity of Systemic Treatments: An Undervalued Issue in the Era of Precision Oncology.
Özdemir BC; Csajka C; Dotto GP; Wagner AD
J Clin Oncol; 2018 Sep; 36(26):2680-2683. PubMed ID: 30004815
[No Abstract] [Full Text] [Related]
2. A New Look at Toxicity in the Era of Precision Oncology: Imaging Findings, Their Relationship With Tumor Response, and Effect on Metastasectomy.
Howard SA; Krajewski KM; Jagannathan JP; Braschi-Amirfarzan M; Tirumani SH; Shinagare AB; Ramaiya NH
AJR Am J Roentgenol; 2016 Jul; 207(1):4-14. PubMed ID: 27065346
[TBL] [Abstract][Full Text] [Related]
3. Giving Up on Precision Oncology? Not So Fast!
Warner JL
Clin Transl Sci; 2017 May; 10(3):128-129. PubMed ID: 28146309
[No Abstract] [Full Text] [Related]
4. Molecular Tumor Boards: Realizing Precision Oncology Therapy.
Patel M; Kato SM; Kurzrock R
Clin Pharmacol Ther; 2018 Feb; 103(2):206-209. PubMed ID: 29134641
[TBL] [Abstract][Full Text] [Related]
5. Precision medicine beyond medical oncology: using molecular analysis to guide treatments of colorectal neoplasia.
Molloy MP; Engel A
Expert Rev Gastroenterol Hepatol; 2018 Dec; 12(12):1179-1181. PubMed ID: 30791786
[No Abstract] [Full Text] [Related]
6. Sex Differences in Efficacy and Toxicity of Systemic Cancer Treatments: Role of the Microbiome.
Pala L; Nezi L; De Pas T; Pennacchioli E; Cocorocchio E; Ferrucci P; Conforti F; Goldhirsch A
J Clin Oncol; 2019 Feb; 37(5):439. PubMed ID: 30592644
[No Abstract] [Full Text] [Related]
7. [Orientation of medical oncology treatment in precision medicine era].
Shi Y; Sun Y
Zhonghua Yi Xue Za Zhi; 2015 Aug; 95(31):2518-21. PubMed ID: 26711383
[No Abstract] [Full Text] [Related]
8. Personalized Medicine: Genomics Trials in Oncology.
Hayes DF; Schott AF
Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
[TBL] [Abstract][Full Text] [Related]
9. The future of oncology therapeutics.
Mansinho A; Boni V; de Miguel M; Calvo E
Expert Rev Anticancer Ther; 2017 Jul; 17(7):563-565. PubMed ID: 28504011
[No Abstract] [Full Text] [Related]
10. Chemotherapy Knowledge Base Management in the Era of Precision Oncology.
Rubinstein SM; Sethi T; Venepalli NK; Gyawali B; Schwartz C; Rivera DR; Yang PC; Warner JL
JCO Clin Cancer Inform; 2021 Jan; 5():30-35. PubMed ID: 33411619
[TBL] [Abstract][Full Text] [Related]
11. Precision medicine in pediatric oncology.
Forrest SJ; Geoerger B; Janeway KA
Curr Opin Pediatr; 2018 Feb; 30(1):17-24. PubMed ID: 29189430
[TBL] [Abstract][Full Text] [Related]
12. Ethical considerations of neuro-oncology trial design in the era of precision medicine.
Gupta S; Smith TR; Broekman ML
J Neurooncol; 2017 Aug; 134(1):1-7. PubMed ID: 28555425
[TBL] [Abstract][Full Text] [Related]
13. Role of Imaging in the Era of Precision Medicine.
Giardino A; Gupta S; Olson E; Sepulveda K; Lenchik L; Ivanidze J; Rakow-Penner R; Patel MJ; Subramaniam RM; Ganeshan D
Acad Radiol; 2017 May; 24(5):639-649. PubMed ID: 28131497
[TBL] [Abstract][Full Text] [Related]
14. Nucleoside analogs: ready to enter the era of precision medicine?
Ciccolini J; Serdjebi C; Le Thi Thu H; Lacarelle B; Milano G; Fanciullino R
Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):865-77. PubMed ID: 27218825
[TBL] [Abstract][Full Text] [Related]
15. Delivering on the promise of precision cancer medicine.
Berger MF; Van Allen EM
Genome Med; 2016 Oct; 8(1):110. PubMed ID: 27782852
[No Abstract] [Full Text] [Related]
16. Oncology reimbursement in the era of personalized medicine and big data.
Ward JC
J Oncol Pract; 2014 Mar; 10(2):83-6. PubMed ID: 24633283
[No Abstract] [Full Text] [Related]
17. One-size-fits-all dosing in oncology wastes money, innovation and lives.
Norris DC
Drug Discov Today; 2018 Jan; 23(1):4-6. PubMed ID: 29170137
[No Abstract] [Full Text] [Related]
18. Strategies For Clinical Implementation: Precision Oncology At Three Distinct Institutions.
Nadauld LD; Ford JM; Pritchard D; Brown T
Health Aff (Millwood); 2018 May; 37(5):751-756. PubMed ID: 29733728
[TBL] [Abstract][Full Text] [Related]
19. Interprofessional Management of Toxicities Related to Cancer Precision Medicine.
Abueg KD
Semin Oncol Nurs; 2017 Nov; 33(4):376-383. PubMed ID: 28927762
[TBL] [Abstract][Full Text] [Related]
20. An appraisal of drug development timelines in the Era of precision oncology.
Jardim DL; Schwaederle M; Hong DS; Kurzrock R
Oncotarget; 2016 Aug; 7(33):53037-53046. PubMed ID: 27419632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
